Teva Pharma Issues Positive Update from Reslizumab Phase III
Teva Pharma announced positive new data from Phase III studies of the company’s anti-IL5 monoclonal antibody, reslizumab, in patients with uncontrolled moderate to severe...
Lonza Introduces Services for Rational Vaccine Design
To help address the growing costs and long development timelines facing vaccine manufacturers, Lonza is announcing the launch of the Vaccine Design and Development...
FDA approves Keytruda for advanced melanoma
First PD-1 blocking drug to receive agency approval The U.S. Food and Drug Administration today granted accelerated approval to Keytruda (pembrolizumab) for treatment...
U.S. Marshals seize drug products from Flawless Beauty
New Jersey firm sold unapproved and improperly labeled drugs Various unapproved and improperly labeled drug products that were marketed, sold and distributed via...
Lilly’s Basal Insulin Peglispro Demonstrated HbA1c Superiority Against Lantus® In Phase III Trials In Patients With Type 1 Diabetes
Core Phase III clinical trial program complete; BIL showed consistent HbA1c superiority against comparators Lilly expects U.S. and European regulatory submissions by end of...
CleveXel Pharma partners with Guilin Pharmaceutical to develop two new anti-malarial products
CleveXel Pharma today announces that the company has entered into a new partnering agreement with Guilin Pharmaceutical, a Chinese company located in Shanghai, regarding...
ABBOTT RECEIVES CE MARK FOR FREESTYLE® LIBRE, A REVOLUTIONARY GLUCOSE MONITORING SYSTEM FOR PEOPLE WITH DIABETES
- FREESTYLE LIBRE SYSTEM ELIMINATES ROUTINE FINGER PRICKS FOR GLUCOSE MEASUREMENTS1 AND REQUIRES NO FINGER PRICKS FOR CALIBRATION - AVAILABLE FOR PEOPLE LIVING WITH...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...